Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Endocarditis, Bacterial | 4 | 2018 | 344 | 1.54 | Why? |
Enterococcus faecalis | 2 | 2018 | 126 | 1.32 | Why? |
Vancomycin | 2 | 2018 | 328 | 1.09 | Why? |
Fosfomycin | 2 | 2018 | 48 | 0.87 | Why? |
Ampicillin | 2 | 2018 | 73 | 0.86 | Why? |
Daptomycin | 2 | 2018 | 64 | 0.82 | Why? |
Home Care Services, Hospital-Based | 1 | 2020 | 137 | 0.76 | Why? |
Endocarditis | 3 | 2020 | 368 | 0.74 | Why? |
Imipenem | 1 | 2018 | 57 | 0.71 | Why? |
Aminoglycosides | 1 | 2017 | 94 | 0.66 | Why? |
Gram-Positive Bacterial Infections | 2 | 2018 | 323 | 0.64 | Why? |
Anti-Bacterial Agents | 6 | 2020 | 10083 | 0.63 | Why? |
beta-Lactams | 1 | 2017 | 210 | 0.56 | Why? |
Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 711 | 0.55 | Why? |
Staphylococcus aureus | 1 | 2017 | 844 | 0.41 | Why? |
Publishing | 1 | 2020 | 990 | 0.41 | Why? |
Social Class | 1 | 2017 | 1360 | 0.37 | Why? |
Staphylococcal Infections | 1 | 2017 | 1099 | 0.33 | Why? |
Periodicals as Topic | 1 | 2020 | 1492 | 0.33 | Why? |
Bacteremia | 1 | 2018 | 1372 | 0.32 | Why? |
Ceftriaxone | 2 | 2018 | 365 | 0.30 | Why? |
Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.27 | Why? |
Socioeconomic Factors | 1 | 2017 | 8495 | 0.19 | Why? |
Carnobacteriaceae | 1 | 2018 | 4 | 0.19 | Why? |
Abiotrophia | 1 | 2018 | 4 | 0.19 | Why? |
Drug Synergism | 2 | 2018 | 833 | 0.17 | Why? |
Pneumonia, Pneumococcal | 1 | 2020 | 251 | 0.17 | Why? |
Rabbits | 2 | 2018 | 1171 | 0.16 | Why? |
Prosthesis-Related Infections | 1 | 2020 | 302 | 0.16 | Why? |
Hospitals, Urban | 1 | 2021 | 950 | 0.15 | Why? |
Molecular Typing | 1 | 2017 | 280 | 0.15 | Why? |
Hepatitis, Viral, Human | 1 | 2018 | 196 | 0.15 | Why? |
Poverty Areas | 1 | 2020 | 556 | 0.15 | Why? |
Superinfection | 1 | 2020 | 459 | 0.15 | Why? |
Armed Conflicts | 1 | 2018 | 209 | 0.14 | Why? |
Hospitals, Public | 1 | 2021 | 774 | 0.14 | Why? |
Virulence Factors | 1 | 2017 | 338 | 0.13 | Why? |
Patient Transfer | 1 | 2021 | 898 | 0.13 | Why? |
Community Participation | 1 | 2020 | 605 | 0.13 | Why? |
Drug Therapy, Combination | 2 | 2018 | 7268 | 0.13 | Why? |
Hospitals, Teaching | 1 | 2021 | 1609 | 0.12 | Why? |
Treatment Outcome | 5 | 2020 | 51732 | 0.12 | Why? |
Global Health | 3 | 2021 | 13911 | 0.11 | Why? |
Health Status Disparities | 2 | 2021 | 4072 | 0.11 | Why? |
Spain | 4 | 2021 | 15545 | 0.10 | Why? |
Bibliometrics | 1 | 2018 | 731 | 0.10 | Why? |
Hospitalization | 1 | 2021 | 54280 | 0.10 | Why? |
Kidney Diseases | 1 | 2020 | 1434 | 0.10 | Why? |
Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
Data Collection | 1 | 2018 | 1769 | 0.09 | Why? |
Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.09 | Why? |
Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.08 | Why? |
Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
Survival Analysis | 2 | 2018 | 7592 | 0.08 | Why? |
Humans | 20 | 2021 | 930598 | 0.08 | Why? |
Middle Aged | 8 | 2021 | 270681 | 0.07 | Why? |
Colombia | 2 | 2020 | 1241 | 0.07 | Why? |
Male | 10 | 2021 | 367725 | 0.07 | Why? |
Transplant Recipients | 1 | 2020 | 4982 | 0.07 | Why? |
Ambulatory Care | 1 | 2021 | 4947 | 0.06 | Why? |
Immunosuppressive Agents | 1 | 2020 | 6331 | 0.06 | Why? |
Female | 10 | 2021 | 380317 | 0.06 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
Aged | 7 | 2021 | 215776 | 0.06 | Why? |
Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
Aged, 80 and over | 4 | 2020 | 88759 | 0.05 | Why? |
Healthcare Disparities | 1 | 2018 | 3893 | 0.05 | Why? |
Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
Cloxacillin | 1 | 2018 | 14 | 0.05 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
Adult | 6 | 2020 | 244371 | 0.04 | Why? |
Pandemics | 3 | 2021 | 389249 | 0.04 | Why? |
United Nations | 1 | 2018 | 367 | 0.04 | Why? |
Capacity Building | 1 | 2021 | 683 | 0.04 | Why? |
Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
Hospital Bed Capacity | 1 | 2021 | 1300 | 0.03 | Why? |
Publications | 1 | 2018 | 463 | 0.03 | Why? |
HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
Animals | 2 | 2018 | 78931 | 0.03 | Why? |
Needs Assessment | 1 | 2021 | 2352 | 0.03 | Why? |
History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
Hong Kong | 1 | 2018 | 3361 | 0.02 | Why? |
Social Stigma | 1 | 2018 | 1049 | 0.02 | Why? |
Health Equity | 1 | 2021 | 1223 | 0.02 | Why? |
Health Care Rationing | 1 | 2021 | 2558 | 0.02 | Why? |
Interferons | 1 | 2018 | 2885 | 0.02 | Why? |
Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
Research | 1 | 2018 | 2115 | 0.02 | Why? |
International Cooperation | 1 | 2018 | 3436 | 0.02 | Why? |
Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
Heart Failure | 1 | 2018 | 6638 | 0.01 | Why? |
Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
Health Services Accessibility | 1 | 2018 | 10697 | 0.01 | Why? |
Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
Public Health | 1 | 2018 | 16359 | 0.01 | Why? |
Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
Pericàs's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(98)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_